AKESO (09926.HK): Trustee Buys 336,000 Shares for About HK$21m
On 16 November 2026, AKESO (09926.HK) said the trustee of its 2021 restricted share unit scheme bought 336,000 shares for about HK$21 million in cash.
NewTimeSpace News: On 16 November 2026, Akeso, Inc. (stock code: 09926) announced that its trustee under the 2021 restricted share unit scheme purchased 336,000 shares on the open market that day for a total consideration of approximately HK$21 million.
The purchase stems from the Company's announcement dated 11 June 2026 regarding the proposed on-market share purchase to be conducted by the trustee of the 2021 restricted share unit scheme, and was funded by the Company's existing available cash resources. The Board believes the purchase reflects the Company's confidence in its business outlook and future prospects.
- AKESO (09926.HK): FDA Issues CRL on Ivonescimab US BLA
- AKESO (09926.HK): Phase III Results for Ivonescimab in First-Line Biliary Tract Cancer at ESMO
- AKESO (09926.HK): Completes 20m-share placing, nets HK$1.94bn
- Biotech Index Hits a Year-to-Date High as Innovative Drug and CXO Names Rally; CSOP Hang Seng Biotech ETF (3174.HK) Gains 3.18% and Is Up 17.93% Year-to-Date
- AKESO (09926.HK): HARMONi-2 interim analysis of ivonescimab meets key secondary OS endpoint with statistical significance and clinical benefit